• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学分析评估 VHL 恢复后信号变化,并鉴定透明细胞肾细胞癌细胞系中潜在的 VHL 底物。

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines.

机构信息

Fundamental Research Center, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.

Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46556, USA.

出版信息

Cells. 2022 Jan 29;11(3):472. doi: 10.3390/cells11030472.

DOI:10.3390/cells11030472
PMID:35159281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8833913/
Abstract

The inactivation of von Hippel-Lindau (VHL) is critical for clear cell renal cell carcinoma (ccRCC) and VHL syndrome. VHL loss leads to the stabilization of hypoxia-inducible factor α (HIFα) and other substrate proteins, which, together, drive various tumor-promoting pathways. There is inadequate molecular characterization of VHL restoration in VHL-defective ccRCC cells. The identities of HIF-independent VHL substrates remain elusive. We reinstalled VHL expression in 786-O and performed transcriptome, proteome and ubiquitome profiling to assess the molecular impact. The transcriptome and proteome analysis revealed that VHL restoration caused the downregulation of hypoxia signaling, glycolysis, E2F targets, and mTORC1 signaling, and the upregulation of fatty acid metabolism. Proteome and ubiquitome co-analysis, together with the ccRCC CPTAC data, enlisted 57 proteins that were ubiquitinated and downregulated by VHL restoration and upregulated in human ccRCC. Among them, we confirmed the reduction of TGFBI (ubiquitinated at K676) and NFKB2 (ubiquitinated at K72 and K741) by VHL re-expression in 786-O. Immunoprecipitation assay showed the physical interaction between VHL and NFKB2. K72 of NFKB2 affected NFKB2 stability in a VHL-dependent manner. Taken together, our study generates a comprehensive molecular catalog of a VHL-restored 786-O model and provides a list of putative VHL-dependent ubiquitination substrates, including TGFBI and NFKB2, for future investigation.

摘要

von Hippel-Lindau(VHL)失活对于透明细胞肾细胞癌(ccRCC)和 VHL 综合征至关重要。VHL 缺失导致缺氧诱导因子α(HIFα)和其他底物蛋白的稳定,这些蛋白共同驱动各种促进肿瘤的途径。VHL 缺陷型 ccRCC 细胞中 VHL 恢复的分子特征描述不足,HIF 非依赖性 VHL 底物的身份仍然难以捉摸。我们在 786-O 细胞中重新安装 VHL 表达,并进行转录组、蛋白质组和泛素组谱分析,以评估分子影响。转录组和蛋白质组分析表明,VHL 恢复导致缺氧信号、糖酵解、E2F 靶标和 mTORC1 信号下调,以及脂肪酸代谢上调。蛋白质组和泛素组联合分析,以及 ccRCC CPTAC 数据,确定了 57 种由 VHL 恢复导致的泛素化和下调,并在人类 ccRCC 中上调的蛋白质。其中,我们通过在 786-O 中重新表达 VHL 证实了 TGFBI(在 K676 泛素化)和 NFKB2(在 K72 和 K741 泛素化)的减少。免疫沉淀实验表明 VHL 与 NFKB2 之间存在物理相互作用。NFKB2 的 K72 以 VHL 依赖的方式影响 NFKB2 的稳定性。总之,我们的研究生成了一个全面的 VHL 恢复的 786-O 模型的分子目录,并提供了一个可能的 VHL 依赖性泛素化底物的列表,包括 TGFBI 和 NFKB2,以供未来研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/0a3f42eb96a7/cells-11-00472-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/274012dfcf43/cells-11-00472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/2a2902e9b7df/cells-11-00472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/cd298527f2de/cells-11-00472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/67d6a84ddfce/cells-11-00472-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/4e378dc47ede/cells-11-00472-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/0a3f42eb96a7/cells-11-00472-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/274012dfcf43/cells-11-00472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/2a2902e9b7df/cells-11-00472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/cd298527f2de/cells-11-00472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/67d6a84ddfce/cells-11-00472-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/4e378dc47ede/cells-11-00472-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6919/8833913/0a3f42eb96a7/cells-11-00472-g006.jpg

相似文献

1
Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines.多组学分析评估 VHL 恢复后信号变化,并鉴定透明细胞肾细胞癌细胞系中潜在的 VHL 底物。
Cells. 2022 Jan 29;11(3):472. doi: 10.3390/cells11030472.
2
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.硒通过脯氨酰羟化酶 2 依赖性和 von Hippel-Lindau 非依赖性降解,抑制肾透明细胞癌细胞中低氧诱导因子 1 和 2α,从而抑制肿瘤生长。
BMC Cancer. 2012 Jul 17;12:293. doi: 10.1186/1471-2407-12-293.
3
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.von Hippel-Lindau 肿瘤抑制蛋白通过组蛋白去甲基酶 JARID1C 调节基因表达和肿瘤生长。
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
4
Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.在透明细胞肾细胞癌中,冯·希佩尔-林道(VHL)的突变版本可保护缺氧诱导因子1α(HIF1α)免受SART1介导的降解。
Oncogene. 2016 Feb 4;35(5):587-94. doi: 10.1038/onc.2015.113. Epub 2015 Apr 27.
5
Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.依米丁促进肾透明细胞癌中缺氧诱导因子-2α的 von Hippel-Lindau 非依赖性降解。
Mol Pharmacol. 2010 Dec;78(6):1072-8. doi: 10.1124/mol.110.066514. Epub 2010 Sep 2.
6
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.在透明细胞肾细胞癌中,p53结合域的VHL错义突变对p53信号传导和HIFα降解表现出不同影响。
Oncotarget. 2017 Feb 7;8(6):10199-10212. doi: 10.18632/oncotarget.14372.
7
The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.von Hippel-Lindau 肿瘤抑制蛋白促进 c-Cbl 非依赖性的 EGFR 激活体多泛素化和降解。
PLoS One. 2011;6(9):e23936. doi: 10.1371/journal.pone.0023936. Epub 2011 Sep 16.
8
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.通过表达阵列分析鉴定细胞周期蛋白D1和其他与希佩尔-林道肿瘤抑制基因相关的新靶点,并研究细胞周期蛋白D1基因型作为希佩尔-林道病的修饰因子。
Cancer Res. 2002 Jul 1;62(13):3803-11.
9
[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].[缺氧诱导因子-1、2α在散发性透明细胞肾细胞癌中的表达及其与冯·希佩尔-林道基因变异的关系]
Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3.
10
TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.TGFBI 促进人肾透明细胞癌细胞的黏附、迁移和侵袭依赖于 von Hippel-Lindau 肿瘤抑制因子失活。
Urology. 2012 Apr;79(4):966.e1-7. doi: 10.1016/j.urology.2011.12.011. Epub 2012 Feb 15.

引用本文的文献

1
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.TRAIL/TNFSF10在VHL缺陷型肾细胞癌中的合成必需性
bioRxiv. 2025 May 30:2025.05.29.621197. doi: 10.1101/2025.05.29.621197.
2
In Silico Exploration of AHR-HIF Pathway Interplay: Implications for Therapeutic Targeting in ccRCC.AHR-HIF 通路相互作用的计算机探索:在 ccRCC 治疗靶点中的意义。
Genes (Basel). 2024 Sep 5;15(9):1167. doi: 10.3390/genes15091167.
3
HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis.

本文引用的文献

1
Belzutifan: First Approval.贝曲妥珠单抗:首次获批。
Drugs. 2021 Nov;81(16):1921-1927. doi: 10.1007/s40265-021-01606-x.
2
Quantitative Proteomics Identifies Secreted Diagnostic Biomarkers as well as Tumor-Dependent Prognostic Targets for Clear Cell Renal Cell Carcinoma.定量蛋白质组学鉴定出透明细胞肾细胞癌的分泌诊断生物标志物和肿瘤依赖性预后靶标。
Mol Cancer Res. 2021 Aug;19(8):1322-1337. doi: 10.1158/1541-7786.MCR-21-0004. Epub 2021 May 11.
3
The role of the extracellular matrix protein TGFBI in cancer.细胞外基质蛋白TGFBI在癌症中的作用。
HOOK1 通过 TGF-β 和 TNFSF13B/VEGF-A 轴抑制肾细胞癌的进展。
Adv Sci (Weinh). 2023 Jun;10(17):e2206955. doi: 10.1002/advs.202206955. Epub 2023 Apr 21.
4
Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma.转录组图谱与尿液标志物的综合分析揭示了透明细胞肾细胞癌的预后生物标志物。
Front Oncol. 2023 Mar 24;13:1102623. doi: 10.3389/fonc.2023.1102623. eCollection 2023.
5
Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌肿瘤微环境靶向治疗的研究进展。
Cancer Control. 2023 Jan-Dec;30:10732748231155700. doi: 10.1177/10732748231155700.
6
Tumor hypoxia: From basic knowledge to therapeutic implications.肿瘤缺氧:从基础知识到治疗意义。
Semin Cancer Biol. 2023 Jan;88:172-186. doi: 10.1016/j.semcancer.2022.12.011. Epub 2023 Jan 2.
7
The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的细胞外基质环境
Cancers (Basel). 2022 Aug 23;14(17):4072. doi: 10.3390/cancers14174072.
8
Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis.系统性鉴定关键细胞外蛋白作为狼疮肾炎潜在的生物标志物。
Front Immunol. 2022 Jul 28;13:915784. doi: 10.3389/fimmu.2022.915784. eCollection 2022.
9
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone.细胞外囊泡的多组学整合方法:一个未来具有挑战性的里程碑。
Proteomes. 2022 Apr 22;10(2):12. doi: 10.3390/proteomes10020012.
Cell Signal. 2021 Aug;84:110028. doi: 10.1016/j.cellsig.2021.110028. Epub 2021 Apr 30.
4
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.用贝佐蒂凡抑制肾细胞癌中的缺氧诱导因子-2α:一项1期试验及生物标志物分析
Nat Med. 2021 May;27(5):802-805. doi: 10.1038/s41591-021-01324-7. Epub 2021 Apr 22.
5
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.透明细胞肾细胞癌的发生机制及致死机制。
Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
6
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.乙酰化 K676 TGFBIp 作为 SARS-CoV-2 肺炎严重程度的诊断性血液生物标志物。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc1564. Print 2020 Jul.
7
Interaction with p53 explains a pro-proliferative function for VHL in cancer.与 p53 的相互作用解释了 VHL 在癌症中具有促进增殖的功能。
J Mol Med (Berl). 2020 Sep;98(9):1269-1278. doi: 10.1007/s00109-020-01951-6. Epub 2020 Jul 28.
8
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.体细胞改变与免疫浸润的相互作用调节晚期透明细胞肾细胞癌对 PD-1 阻断的反应。
Nat Med. 2020 Jun;26(6):909-918. doi: 10.1038/s41591-020-0839-y. Epub 2020 May 29.
9
Effective combinatorial immunotherapy for penile squamous cell carcinoma.阴茎鳞状细胞癌的有效组合免疫疗法。
Nat Commun. 2020 May 1;11(1):2124. doi: 10.1038/s41467-020-15980-9.
10
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond.癌症中缺氧诱导的上皮-间质转化:HIF-1α及其他因素
Front Oncol. 2020 Apr 8;10:486. doi: 10.3389/fonc.2020.00486. eCollection 2020.